» Articles » PMID: 24113890

Coating with Artificial Matrices from Collagen and Sulfated Hyaluronan Influences the Osseointegration of Dental Implants

Overview
Publisher Springer
Date 2013 Oct 12
PMID 24113890
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Dental implants are an established therapy for oral rehabilitation. High success rates are achieved in healthy bone, however, these rates decrease in compromised host bone. Coating of dental implants with components of the extracellular matrix is a promising approach to enhance osseointegration in compromised peri-implant bone. Dental titanium implants were coated with an artificial extracellular matrix (aECM) consisting of collagen type I and either one of two regioselectively low sulfated hyaluronan (sHA) derivatives (coll/sHA1Δ6s and coll/sHA1) and compared to commercial pure titanium implants (control). After extraction of the premolar teeth, 36 implants were inserted into the maxilla of 6 miniature pigs (6 implants per maxilla). The healing periods were 4 and 8 weeks, respectively. After animal sacrifice, the samples were evaluated histomorphologically and histomorphometrically. All surface states led to a sufficient implant osseointegration after 4 and 8 weeks. Inflammatory or foreign body reactions could not be observed. After 4 weeks of healing, implants coated with coll/sHA1Δ6s showed the highest bone implant contact (BIC; coll/sHA1Δ6s: 45.4%; coll/sHA1: 42.2%; control: 42.3%). After 8 weeks, a decrease of BIC could be observed for coll/sHA1Δ6s and controls (coll/sHA1Δ6s: 37.3%; control: 31.7 %). For implants coated with coll/sHA1, the bone implant contact increased (coll/sHA1: 50.8%). Statistically significant differences could not be observed. Within the limits of the current study, aECM coatings containing low sHA increase peri-implant bone formation around dental implants in maxillary bone compared to controls in the early healing period.

Citing Articles

Construction of functional surfaces for dental implants to enhance osseointegration.

Wang Z, Wang J, Wu R, Wei J Front Bioeng Biotechnol. 2023; 11:1320307.

PMID: 38033823 PMC: 10682203. DOI: 10.3389/fbioe.2023.1320307.


Novel clinical trial design and analytic methods to tackle challenges in therapeutic development in rare diseases.

Li Y, Izem R Ann Transl Med. 2022; 10(18):1034.

PMID: 36267797 PMC: 9577738. DOI: 10.21037/atm-21-5496.


Fabrication of Low-Molecular-Weight Hyaluronic Acid-Carboxymethyl Cellulose Hybrid to Promote Bone Growth in Guided Bone Regeneration Surgery: An Animal Study.

Lin C, Kuo P, Lin Y, Lin C, Chin-Yi Lin J, Chiu H Polymers (Basel). 2022; 14(15).

PMID: 35956724 PMC: 9370888. DOI: 10.3390/polym14153211.


Efficacy of hyaluronic acid, absorbable collagen sponge, and their combination in minimizing bisphosphonate-related osteonecrosis of the jaws (BRONJ) after dental extraction: a preliminary animal histomorphometric study.

Sarkarat F, Modarresi A, Riyahi A, Mortazavi P, Tabandeh F, Rakhshan V Maxillofac Plast Reconstr Surg. 2022; 44(1):8.

PMID: 35230522 PMC: 8888787. DOI: 10.1186/s40902-022-00337-7.


The minipig intraoral dental implant model: A systematic review and meta-analysis.

Musskopf M, Finger Stadler A, Wikesjo U, Susin C PLoS One. 2022; 17(2):e0264475.

PMID: 35226690 PMC: 8884544. DOI: 10.1371/journal.pone.0264475.


References
1.
Franz S, Allenstein F, Kajahn J, Forstreuter I, Hintze V, Moller S . Artificial extracellular matrices composed of collagen I and high-sulfated hyaluronan promote phenotypic and functional modulation of human pro-inflammatory M1 macrophages. Acta Biomater. 2012; 9(3):5621-9. DOI: 10.1016/j.actbio.2012.11.016. View

2.
Branemark P, Hansson B, Adell R, BREINE U, Lindstrom J, HALLEN O . Osseointegrated implants in the treatment of the edentulous jaw. Experience from a 10-year period. Scand J Plast Reconstr Surg Suppl. 1977; 16:1-132. View

3.
Bierbaum S, Douglas T, Hanke T, Scharnweber D, Tippelt S, Monsees T . Collageneous matrix coatings on titanium implants modified with decorin and chondroitin sulfate: characterization and influence on osteoblastic cells. J Biomed Mater Res A. 2006; 77(3):551-62. DOI: 10.1002/jbm.a.30572. View

4.
Terheyden H, Lang N, Bierbaum S, Stadlinger B . Osseointegration--communication of cells. Clin Oral Implants Res. 2011; 23(10):1127-35. DOI: 10.1111/j.1600-0501.2011.02327.x. View

5.
Takahashi K, Goomer R, Harwood F, Kubo T, Hirasawa Y, Amiel D . The effects of hyaluronan on matrix metalloproteinase-3 (MMP-3), interleukin-1beta(IL-1beta), and tissue inhibitor of metalloproteinase-1 (TIMP-1) gene expression during the development of osteoarthritis. Osteoarthritis Cartilage. 1999; 7(2):182-90. DOI: 10.1053/joca.1998.0207. View